Loading live market data…

Rapport Therapeutics, Inc. Common Stock

NASDAQ:RAPP

$41.46 USD

$0.87 (2.14%)

Volume
404.83K
Average Volume
385.25K
Market Capitalization
$1.51B
P/E Ratio
-15.95
Dividend Yield
0.00%
Price Target
$56.00
Year High
$43.76
Year Low
$13.62
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$27.08

RAPP Estimated and Actual Revenue by Quarter

RAPP Estimated and Actual EPS by Quarter

RAPP Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 3 - - - - - -
2027-09-30 2 - - - - - -
2027-06-30 2 - - - - - -
2027-03-31 3 - - - - - -
2026-12-31 3 - - - - - -
2026-09-30 2 - - - - - -
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 3 -56.97M -56.97M -56.97M - - -
2027-09-30 2 -55.36M -55.36M -55.36M - - -
2027-06-30 2 -54.04M -54.04M -54.04M - - -
2027-03-31 3 -52.83M -52.83M -52.83M - - -
2026-12-31 3 -49.94M -49.94M -49.94M - - -
2026-09-30 2 -49.36M -45.87M -47.37M - - -
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 3 20M 20M 20M 1 -1.206 -1.206 -1.206
2027-09-30 2 20M 20M 20M 1 -1.172 -1.172 -1.172
2027-06-30 2 20M 20M 20M 1 -1.144 -1.144 -1.144
2027-03-31 3 20M 20M 20M 1 -1.11833 -1.11833 -1.11833
2026-12-31 3 20M 20M 20M 1 -1.05727 -1.05727 -1.05727
2026-09-30 2 20M 20M 20M 5 -1.04495 -0.97106 -1.00273